| Family Medical Associates, P.a. | |
|
146 Highway 32 2a Ashdown AR 71822-8689 | |
| (870) 898-5525 | |
| (870) 898-8572 |
| Full Name | Family Medical Associates, P.a. |
|---|---|
| Speciality | Family Medicine |
| Location | 146 Highway 32 2a, Ashdown, Arkansas |
| Authorized Official Name and Position | Vernon Dean Bowman (OWNER) |
| Authorized Official Contact | 8708985525 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Medical Associates, P.a. 146 Highway 32 2a Ashdown AR 71822-8689 Ph: (870) 898-5525 | Family Medical Associates, P.a. 146 Highway 32 2a Ashdown AR 71822-8689 Ph: (870) 898-5525 |
| NPI Number | 1346274511 |
|---|---|
| Provider Enumeration Date | 07/11/2006 |
| Last Update Date | 04/03/2008 |
| Medicare PECOS PAC ID | 9739276635 |
|---|---|
| Medicare Enrollment ID | O20071024000390 |
News Archive
Australian scientists from the Institute for Molecular Bioscience at The University of Queensland (UQ), have identified a gene which could very well 'knock the sox' off cancer and lymphatic disorders.
People under the age of 25 contribute an estimated 38% of reported voluntary blood donations, according to new global data from the WHO, released on World Blood Donor Day, 14 June.
Guided Therapeutics, Inc. announced that it received a $244,479 Federal grant to advance its LightTouch™ Cervical Scanner, currently under FDA review for market approval.
Array BioPharma Inc. today announced that it has entered into an agreement with Novartis for the worldwide development of the small-molecule MEK inhibitors ARRY-162, currently in a Phase 1 cancer trial, its back-up, ARRY-300, and other MEK inhibitors.
In 2011, the Food and Drug Law Institute will launch a new publication — FDLI"s Food and Drug Policy Forum. "The Policy Forum is designed to provide a new electronic marketplace for the exchange of ideas among food and drug law, regulation, and policy professionals," notes Susan C. Winckler, President and CEO of FDLI.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346274511 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Vernon D Bowman |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1053311068 PECOS PAC ID: 1557344595 Enrollment ID: I20071024000463 |
News Archive
Australian scientists from the Institute for Molecular Bioscience at The University of Queensland (UQ), have identified a gene which could very well 'knock the sox' off cancer and lymphatic disorders.
People under the age of 25 contribute an estimated 38% of reported voluntary blood donations, according to new global data from the WHO, released on World Blood Donor Day, 14 June.
Guided Therapeutics, Inc. announced that it received a $244,479 Federal grant to advance its LightTouch™ Cervical Scanner, currently under FDA review for market approval.
Array BioPharma Inc. today announced that it has entered into an agreement with Novartis for the worldwide development of the small-molecule MEK inhibitors ARRY-162, currently in a Phase 1 cancer trial, its back-up, ARRY-300, and other MEK inhibitors.
In 2011, the Food and Drug Law Institute will launch a new publication — FDLI"s Food and Drug Policy Forum. "The Policy Forum is designed to provide a new electronic marketplace for the exchange of ideas among food and drug law, regulation, and policy professionals," notes Susan C. Winckler, President and CEO of FDLI.
› Verified 4 days ago
News Archive
Australian scientists from the Institute for Molecular Bioscience at The University of Queensland (UQ), have identified a gene which could very well 'knock the sox' off cancer and lymphatic disorders.
People under the age of 25 contribute an estimated 38% of reported voluntary blood donations, according to new global data from the WHO, released on World Blood Donor Day, 14 June.
Guided Therapeutics, Inc. announced that it received a $244,479 Federal grant to advance its LightTouch™ Cervical Scanner, currently under FDA review for market approval.
Array BioPharma Inc. today announced that it has entered into an agreement with Novartis for the worldwide development of the small-molecule MEK inhibitors ARRY-162, currently in a Phase 1 cancer trial, its back-up, ARRY-300, and other MEK inhibitors.
In 2011, the Food and Drug Law Institute will launch a new publication — FDLI"s Food and Drug Policy Forum. "The Policy Forum is designed to provide a new electronic marketplace for the exchange of ideas among food and drug law, regulation, and policy professionals," notes Susan C. Winckler, President and CEO of FDLI.
› Verified 4 days ago
George K Covert Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 181 West Main, Ashdown, AR 71822 Phone: 870-898-6940 Fax: 870-898-4191 | |
Kevin C Kleinschmidt Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 418 N Second St, Ashdown, AR 71822 Phone: 870-898-5037 Fax: 870-898-3910 | |
Access Medical Clinic Arkansas, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 122 Southern Dr, Ashdown, AR 71822 Phone: 870-600-4050 | |
Khoa Cao Nguyen Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1340 S Constitution Ave, Ashdown, AR 71822 Phone: 870-898-2007 | |
Little River Memorial Hospital Emergency Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 451 W Locke St, Ashdown, AR 71822 Phone: 870-898-5011 Fax: 870-898-4172 | |
Rachel C. King Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 180 Hwy. 71 South, Ashdown, AR 71822 Phone: 870-898-5464 |